Diabetes Care, Vol 19, Issue 9 998-1000, Copyright © 1996 by American Diabetes Association

ARTICLES

High prevalence of hepatitis C virus infection in diabetic patients

R Simo, C Hernandez, J Genesca, R Jardi and J Mesa
Department of Endocrinology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

OBJECTIVE: To evaluate the prevalence of hepatitis C virus (HCV) infection in diabetic patients and to investigate the influence of several epidemiological and clinical factors on HCV infection. RESEARCH DESIGN AND METHODS: A total of 176 consecutive diabetic patients were compared with 6,172 blood donors, matched by recognized risk factors to acquire HCV infection. Serologic testing for anti-HCV was done using a second-generation commercial enzyme-linked immunosorbent assay (ELISA) and an immunoblot assay was performed in anti-HCV positive samples to confirm HCV specificity. Diabetic patients were divided in two groups according to their HCV antibody status and analyzed for the following variables: age, sex, type of diabetes, duration of disease, mode of therapy, late diabetic complications, previous blood transfusions, intravenous drug addiction, hospital admissions, major surgical procedures, and liver function tests (LFTs). RESULTS: A higher prevalence of HCV infection was observed in diabetic patients in comparison with blood donors (11.5 vs. 2.5%; P < 0.001; odds ratio 4.39; 95% Cl2.61-7.24). We did not detect any particular epidemiological factor for HCV infection in anti-HCV positive diabetic patients. In these patients, abnormal LFTs were observed in 72.3%, compared with only 24.7% of anti-HCV negative diabetic patients (P < 0.001). CONCLUSIONS: A high prevalence of HCV infection was detected in diabetic patients, and most of anti-HCV positive patients presented with abnormal LFTs. Therefore, testing for HCV infection of diabetic patients with an abnormal LFT is mandatory. The lack of any particular epidemiological factor for HCV infection in our diabetic population suggests that HCV may have a direct role in the development of diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. R. Gosmanov and G. E. Umpierrez A Patient with Diabetes, Hepatitis C Virus Infection, and Hemochromatosis Gene Mutation Clin. Diabetes, October 1, 2008; 26(4): 174 - 176. [Full Text] [PDF]

				C.-S. Wang, S.-T. Wang, W.-J. Yao, T.-T. Chang, and P. Chou Hepatitis C Virus Infection and the Development of Type 2 Diabetes in a Community-based Longitudinal Study Am. J. Epidemiol., July 15, 2007; 166(2): 196 - 203. [Abstract] [Full Text] [PDF]

				K. G. Tolman, V. Fonseca, A. Dalpiaz, and M. H. Tan Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver Disease Diabetes Care, March 1, 2007; 30(3): 734 - 743. [Full Text] [PDF]

				M. F. Crutchlow and R. D. Bloom Transplant-Associated Hyperglycemia: A New Look at an Old Problem Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 343 - 355. [Abstract] [Full Text] [PDF]

				A. Lecube, C. Hernandez, J. Genesca, and R. Simo Glucose Abnormalities in Patients with Hepatitis C Virus Infection: Epidemiology and pathogenesis Diabetes Care, May 1, 2006; 29(5): 1140 - 1149. [Full Text] [PDF]

				E. D. Crook, S. Penumalee, B. Gavini, and K. Filippova Hepatitis C Is a Predictor of Poorer Renal Survival in Diabetic Patients Diabetes Care, September 1, 2005; 28(9): 2187 - 2191. [Abstract] [Full Text] [PDF]

				E. H. Harris Elevated Liver Function Tests in Type 2 Diabetes Clin. Diabetes, July 1, 2005; 23(3): 115 - 119. [Abstract] [Full Text] [PDF]

				K. G. Tolman, V. Fonseca, M. H. Tan, and A. Dalpiaz Narrative Review: Hepatobiliary Disease in Type 2 Diabetes Mellitus Ann Intern Med, December 21, 2004; 141(12): 946 - 956. [Abstract] [Full Text] [PDF]

				A. Lecube, C. Hernandez, J. Genesca, J. I. Esteban, R. Jardi, L. Garcia, and R. Simo Diabetes Is the Main Factor Accounting for the High Ferritin Levels Detected in Chronic Hepatitis C Virus Infection Diabetes Care, November 1, 2004; 27(11): 2669 - 2675. [Abstract] [Full Text] [PDF]

				T. Kawaguchi, T. Yoshida, M. Harada, T. Hisamoto, Y. Nagao, T. Ide, E. Taniguchi, H. Kumemura, S. Hanada, M. Maeyama, et al. Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3 Am. J. Pathol., November 1, 2004; 165(5): 1499 - 1508. [Abstract] [Full Text] [PDF]

				C. Wilson Hepatitis C Infection and Type 2 Diabetes in American-Indian Women Diabetes Care, September 1, 2004; 27(9): 2116 - 2119. [Abstract] [Full Text] [PDF]

				A. Lecube, C. Hernandez, J. Genesca, J. I. Esteban, R. Jardi, and R. Simo High Prevalence of Glucose Abnormalities in Patients With Hepatitis C Virus Infection: A multivariate analysis considering the liver injury Diabetes Care, May 1, 2004; 27(5): 1171 - 1175. [Abstract] [Full Text] [PDF]

				C.-S. Wang, S.-T. Wang, W.-J. Yao, T.-T. Chang, and P. Chou Community-based Study of Hepatitis C Virus Infection and Type 2 Diabetes: An Association Affected by Age and Hepatitis Severity Status Am. J. Epidemiol., December 15, 2003; 158(12): 1154 - 1160. [Abstract] [Full Text] [PDF]

				G. Verlato, G. Zoppini, E. Bonora, and M. Muggeo Mortality From Site-Specific Malignancies in Type 2 Diabetic Patients From Verona Diabetes Care, April 1, 2003; 26(4): 1047 - 1051. [Abstract] [Full Text] [PDF]

				M. Fukui, Y. Kitagawa, N. Nakamura, and T. Yoshikawa Hepatitis C Virus and Atherosclerosis in Patients With Type 2 Diabetes JAMA, March 12, 2003; 289(10): 1245 - 1246. [Full Text] [PDF]

				M. A. Gentil, E. Luna, G. Rodriguez-Algarra, A. Osuna, M. Gonzalez-Molina, A. Mazuecos, J. J. Cubero, and D. del Castillo Incidence of diabetes mellitus requiring insulin treatment after renal transplantation in patients with hepatitis C Nephrol. Dial. Transplant., May 1, 2002; 17(5): 887 - 891. [Abstract] [Full Text] [PDF]

				O. Oncul, C. Top, and T. Cavuthlu Correlation of Serum Leptin Levels With Insulin Sensitivity in Patients With Chronic Hepatitis-C Infection Diabetes Care, May 1, 2002; 25(5): 937 - 937. [Full Text]

				A. Mason Viral Induction of Type 2 Diabetes and Autoimmune Liver Disease J. Nutr., October 1, 2001; 131(10): 2805S - 2808. [Abstract] [Full Text] [PDF]

				S. H. Mehta, F. L. Brancati, M. S. Sulkowski, S. A. Strathdee, M. Szklo, and D. L. Thomas Prevalence of Type 2 Diabetes Mellitus among Persons with Hepatitis C Virus Infection in the United States Ann Intern Med, October 17, 2000; 133(8): 592 - 599. [Abstract] [Full Text] [PDF]

				G. J.M. Alexander An Association between Hepatitis C Virus Infection and Type 2 Diabetes Mellitus: What Is the Connection? Ann Intern Med, October 17, 2000; 133(8): 650 - 652. [Full Text] [PDF]

				J. SOMA, T. SAITO, Y. TAGUMA, S. CHIBA, H. SATO, K. SUGIMURA, S. OGAWA, and S. ITO High Prevalence and Adverse Effect of Hepatitis C Virus Infection in Type II Diabetic-Related Nephropathy J. Am. Soc. Nephrol., April 1, 2000; 11(4): 690 - 699. [Abstract] [Full Text] [PDF]